Purpose
to develop optimized aluminium-based formulations of IPV vaccine to achieve dose-reduction with the ultimate goal of accelerating polio eradication and pursue safe vaccination during the post-eradication era.
Grantee
Division
Global Health
Date
NOVEMBER 2012
Region served
GLOBAL
Committed amount
$110,641
Grant topic
Discovery and Translational Sciences
Duration (months)
48
Grantee location
Lausanne, Switzerland
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.